Company intelligence / Profile preview

WeWALK

London, England, United Kingdomwewalk.io ↗

Ownership: Private
Employees: ~18
Development stage: Commercial

Overview

WeWALK has developed a commercially available smart cane integrated with AI, GPS, and smartphone connectivity to assist visually impaired individuals with navigation, obstacle detection, and independence. The company is expanding its technology to include computer vision features in partnership with leading academic institutions. Its products have received global recognition including TIME Best Invention and Edison Gold Award.

Therapeutic areas: Ophthalmology
Modalities: DeviceDigital health platform
Industry: Assistive Medical Devices

Partnerships

Microsoft (AI development)Imperial College London (R&D collaboration)Royal National Institute of Blind People/RNIB (user testing & ergonomics)Amazon/In Kind Direct charity (distribution partnership in the UK)

Beyond the preview

Go deeper on WeWALK.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on WeWALK.

Explore the full profile